InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,227.60
(
-0.02%
)
Dow Jones
39,872.99
(
0.00%
)
Brent Oil
81.90
(
-0.67%
)
Bitcoin
69,866.85
(
-0.38%
)
Post# of 251889
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 164856

Wednesday, 06/11/2014 2:36:04 PM

Wednesday, June 11, 2014 2:36:04 PM

Post# of 251889

CEO also said Teva will continue to detail regular Copaxone even if they get FDA approval for the thrice-weekly product. This is new information.

That CEO is gone and if the new one is thinking what FRX' was thinking...

Forest Laboratories Announces Intention to Continue Marketing Both NAMENDA® TABLETS and Once-Daily NAMENDA XR® Into the Fall of 2014

https://finance.yahoo.com/news/forest-laboratories-announces-intention-continue-200100630.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up